The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly.
GSK announces availability of Authorized Generic Albuterol Sulfate Inhaler for treatment or prevention of bronchospasm
Effective, January 15, 2019, GSK announced the availability of an authorized generic (AG) of Ventolin HFA (albuterol sulfate) inhalation aerosol. The AG will be manufactured by GSK and distributed by Prasco LLC.
The authorized generic contains the same medicine, with the same instructions for use as Ventolin HFA, however it will have a list price or Wholesale Acquisition Cost (WAC) less than $36. This represents at least a 35% reduction to the current WAC price of branded Ventolin and potentially a lower cost alternative to the patient, depending on a patient’s insurance coverage.
The AG may especially benefit cash paying patients and those covered by high-deductible health plans, who are often responsible for the full retail price of their prescription medicines. It is estimated that about 26% of Commercial and Medicare Part D patients pay $35 or more for their Ventolin HFA prescription1.
In addition to continuing to make the brand available, GSK will work with insurers and pharmacy benefit managers to maintain Ventolin HFA’s strong access and affordability. For those patients without insurance and who qualify, direct patient support to obtain Ventolin HFA is available through our Patient Assistance Program.
About Ventolin HFA
Ventolin HFA is a short-acting beta agonist, commonly referred to as a rescue or reliever medicine and is indicated for treatment or prevention of bronchospasm in patients 4 years and older with reversible obstructive airway disease bronchospasm (please refer to the full prescribing information for additional detail). Short-acting beta agonists are a commonly prescribed medicine with over 70 million units of albuterol sulfate dispensed each year in the United States. Through rapid airway expansion, albuterol sulfate can provide quick relief and enable easier breathing for individuals in respiratory distress.
Please contact the GSK Response Center at 888-825-5249 or contact us online with any questions regarding Ventolin.
1 IQVIA APLD Database July 2018 – September 2018, Normalized